MedPath

Exploratory Study of Effective Core Formula of Chinese Medicine to Treat Primary Insomnia

Not Applicable
Conditions
Primary Insomnia
Interventions
Drug: Chinese herbal Medicine
Other: the dummy of a Chinese Medicine prescription
Registration Number
NCT01613183
Lead Sponsor
China Academy of Chinese Medical Sciences
Brief Summary

The objective of this study is to screen the effective core formulation in insomnia treatment with Chinese medicine with a double-blind, randomized, placebo-controlled trial.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
2
Inclusion Criteria
  • aged between 18 and 65 years,
  • meeting the Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-V) of insomnia,
  • Spiegel scale score is ≥ 18,
  • The informed consent must be obtained from patient
Read More
Exclusion Criteria
  • total sleep time ≤ 2 hours,
  • secondary insomnia,
  • Self-rating Anxiety Scale (SAS) score ≥ 18,
  • Beck Depression Inventory (BDI) score ≥ 6,
  • having hypertension, diabetes, stroke, and coronary heart disease,
  • have drug abuse history,
  • pregnancy or preparing to pregnancy,
  • used immunotherapy or hormone therapy in past 1 years,
  • participating in another clinical trial.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Chinese Medicine groupChinese herbal MedicineChinese Medicine prescription of one of three prestigious Chinese medicine clinicians
placebo groupthe dummy of a Chinese Medicine prescription-
Primary Outcome Measures
NameTimeMethod
change from baseline in Total Sleep Time (TST) at 4 weeksbaseline and 4 weeks
Secondary Outcome Measures
NameTimeMethod
change from baseline in sleep onset latency at 4 weeksbaseline and 4 weeks
change from baseline in wake time after sleep onset at 4 weeksbaseline and 4 weeks
change from baseline in sleep efficiency at 4 weeksbaseline and 4 weeks
change from baseline in Pittsburgh sleep quality index (PSQI) at 4 weeksbaseline and 4 weeks
change from baseline in Chinese Medicine symptoms and signs at 4 weeksbaseline and 4 weeks

Trial Locations

Locations (1)

Guang'anmen hospital, China Academy of Chinese Medical Sciences

🇨🇳

Beijing, China

© Copyright 2025. All Rights Reserved by MedPath